143 related articles for article (PubMed ID: 23435553)
1. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.
Telpoukhovskaia MA; Patrick BO; Rodríguez-Rodríguez C; Orvig C
Mol Biosyst; 2013 Apr; 9(4):792-805. PubMed ID: 23435553
[TBL] [Abstract][Full Text] [Related]
2. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
[TBL] [Abstract][Full Text] [Related]
4. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
[TBL] [Abstract][Full Text] [Related]
5. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
ACS Chem Biol; 2010 Jun; 5(6):603-10. PubMed ID: 20455574
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors.
Imramovský A; Pejchal V; Štěpánková Š; Vorčáková K; Jampílek J; Vančo J; Šimůnek P; Královec K; Brůčková L; Mandíková J; Trejtnar F
Bioorg Med Chem; 2013 Apr; 21(7):1735-48. PubMed ID: 23462716
[TBL] [Abstract][Full Text] [Related]
7. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.
Samadi A; de la Fuente Revenga M; Pérez C; Iriepa I; Moraleda I; Rodríguez-Franco MI; Marco-Contelles J
Eur J Med Chem; 2013 Sep; 67():64-74. PubMed ID: 23838422
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening of acetylcholinesterase inhibitors using the Lipinski's rule of five and ZINC databank.
Nogara PA; Saraiva Rde A; Caeran Bueno D; Lissner LJ; Lenz Dalla Corte C; Braga MM; Rosemberg DB; Rocha JB
Biomed Res Int; 2015; 2015():870389. PubMed ID: 25685814
[TBL] [Abstract][Full Text] [Related]
12. Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
Marco-Contelles J; León R; de los Ríos C; Samadi A; Bartolini M; Andrisano V; Huertas O; Barril X; Luque FJ; Rodríguez-Franco MI; López B; López MG; García AG; Carreiras Mdo C; Villarroya M
J Med Chem; 2009 May; 52(9):2724-32. PubMed ID: 19374444
[TBL] [Abstract][Full Text] [Related]
13. In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity.
da Silva VB; de Andrade P; Kawano DF; Morais PA; de Almeida JR; Carvalho I; Taft CA; da Silva CH
Future Med Chem; 2011 Jun; 3(8):947-60. PubMed ID: 21707398
[TBL] [Abstract][Full Text] [Related]
14. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B; Singh N
Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
[TBL] [Abstract][Full Text] [Related]
15. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
16. Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Tang H; Zhao HT; Zhong SM; Wang ZY; Chen ZF; Liang H
Bioorg Med Chem Lett; 2012 Mar; 22(6):2257-61. PubMed ID: 22341944
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophores.
Lakshmi V; Kannan VS; Boopathy R
J Mol Graph Model; 2013 Mar; 40():72-9. PubMed ID: 23353586
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
Luo Z; Sheng J; Sun Y; Lu C; Yan J; Liu A; Luo HB; Huang L; Li X
J Med Chem; 2013 Nov; 56(22):9089-99. PubMed ID: 24160297
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.
Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A
Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665
[TBL] [Abstract][Full Text] [Related]
20. Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Ramírez L; Viayna E; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Bidon-Chanal A; Huertas O; Dafni T; Luque FJ
Chem Biol Interact; 2010 Sep; 187(1-3):411-5. PubMed ID: 20167211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]